ICUI Earnings Prediction
The chart below shows how ICUI performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ICUI sees a -0.65% change in stock price 10 days leading up to the earnings, and a -2.51% change 10 days following the report. On the earnings day itself, the stock moves by +1.18%. This data can give you a slight idea of what to expect for the next quarter's release.
ICUI Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
589.13M
6.47%
-1.23%
Gross Margin
34.77%
4.60%
-0.03%
Operating Margin
3.58%
37.16%
-12.90%
Net Margin
-5.60%
-527.48%
55.99%
EPS
-1.35
-550.00%
53.41%
No Data Available
ICUI Earnings Analysis
ICU Medical Inc Corporation (ICUI.O) Earnings Conference Call
Positive
Q3 Revenue Growth: Revenue for Q3 was $580 million for total company growth of 7% on a constant currency basis or 6% on a reported basis.
Financial Performance Metrics: Adjusted EBITDA was $95 million and EPS was $1.59.
Gross Margin Improvement: Gross margins were a little higher than expected due to capture of supply chain efficiencies, FX, and sales mix.
Free Cash Flow Generation: We again had a good quarter of free cash flow generation, which enabled us to reduce some of the AR factoring line as previously discussed and our cash balance increased to approximately $313 million.
Healthy Demand Environment: The broader demand and utilization environment in Q3 was healthy across all geographies and it's felt that way this year to date and since we're almost halfway through Q4, we've not really seen any major changes in the environment.
Negative
Q3 Revenue Growth: Revenue for Q3 was $580 million for total company growth of 7% on a constant currency basis or 6% on a reported basis.
Financial Performance Metrics: Adjusted EBITDA was $95 million and EPS was $1.59.
Operating Expenses Increase: Total operating expenses were up 11% year-over-year, reflecting a combination of increased selling expenses from higher revenues and higher incentive compensation.
Healthy Demand Environment: The broader demand and utilization environment in Q3 was healthy across all geographies and it's felt that way this year to date and since we're almost halfway through Q4, we've not really seen any major changes in the environment.
Stable Capital Environment: The capital environment was status quo and the investments that customers need to make are getting made.
ICUI FAQs
How does ICUI typically perform around its earnings report dates?
Is ICU Medical Inc. (ICUI) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
ICUI Earning Call Sentiment
ICU Medical Inc. (ICUI) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
ICUI.O
-3.61%Positive
The earnings call presents a mixed but generally positive outlook. Financial performance shows growth in revenue and gross margin, with a strategic joint venture providing a significant upfront payment to reduce debt. Despite some risks in market concentration and debt levels, guidance remains optimistic with improved EBITDA and EPS expectations. The Q&A reveals management's confidence in their competitive position and long-term strategy. The market cap suggests a moderate reaction, leading to a positive prediction for stock movement, likely between 2% to 8% over the next two weeks.
